Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 35
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Fialho, Renata Pereira, Marco Bucur, Mihaela Fisher, Martin Whale, Richard and Rusted, Jennifer 2016. Cognitive impairment in HIV and HCV co-infected patients: a systematic review and meta-analysis. AIDS Care, Vol. 28, Issue. 12, p. 1481.

    Kurapati, Kesava Rao V. Atluri, Venkata S. Samikkannu, Thangavel Garcia, Gabriella and Nair, Madhavan P. N. 2016. Natural Products as Anti-HIV Agents and Role in HIV-Associated Neurocognitive Disorders (HAND): A Brief Overview. Frontiers in Microbiology, Vol. 6,

    Li, Weizhe Tong, Hsin-I Gorantla, Santhi Poluektova, Larisa Y Gendelman, Howard E and Lu, Yuanan 2016. Neuropharmacologic Approaches to Restore the Brain’s Microenvironment. Journal of Neuroimmune Pharmacology, Vol. 11, Issue. 3, p. 484.

    Okafor, Chukwuemeka N. Kelso, Natalie E. Bryant, Vaughn Burrell, Larry E. Míguez, Maria Jose Gongvatana, Assawin Tashima, Karen T. de la Monte, Suzanne Cook, Robert L. and Cohen, Ronald A. 2016. Body mass index, inflammatory biomarkers and neurocognitive impairment in HIV-infected persons. Psychology, Health & Medicine, p. 1.

    Park, Lesley S. Hernández-Ramírez, Raúl U. Silverberg, Michael J. Crothers, Kristina and Dubrow, Robert 2016. Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS. AIDS, Vol. 30, Issue. 2, p. 273.

    Seider, Talia R. Gongvatana, Assawin Woods, Adam J. Chen, Huaihou Porges, Eric C. Cummings, Tiffany Correia, Stephen Tashima, Karen and Cohen, Ronald A. 2016. Age exacerbates HIV-associated white matter abnormalities. Journal of NeuroVirology, Vol. 22, Issue. 2, p. 201.

    Vázquez-Justo, Enrique Vergara-Moragues, Esperanza Blanco, Adolfo Piñón Gestoso, Carlos Guillén and Pérez-García, Miguel 2016. Neuropsychological functioning in methadone maintenance patients with HIV. Revista Latinoamericana de Psicología, Vol. 48, Issue. 3, p. 147.

    Wray, Tyler B. Pantalone, David W. Kahler, Christopher W. Monti, Peter M. and Mayer, Kenneth H. 2016. The role of discrimination in alcohol-related problems in samples of heavy drinking HIV-negative and positive men who have sex with men (MSM). Drug and Alcohol Dependence, Vol. 166, p. 226.

    Bertrand, Sarah J. Hu, Calvin Aksenova, Marina V. Mactutus, Charles F. and Booze, Rosemarie M. 2015. HIV-1 Tat and cocaine mediated synaptopathy in cortical and midbrain neurons is prevented by the isoflavone Equol. Frontiers in Microbiology, Vol. 6,

    Bryant, Vaughn E. Whitehead, Nicole E. Burrell, Larry E. Dotson, Vonetta M. Cook, Robert L. Malloy, Paul Devlin, Kathryn and Cohen, Ronald A. 2015. Depression and Apathy Among People Living with HIV: Implications for Treatment of HIV Associated Neurocognitive Disorders. AIDS and Behavior, Vol. 19, Issue. 8, p. 1430.

    Cohen, Ronald A Seider, Talia R and Navia, Bradford 2015. HIV effects on age-associated neurocognitive dysfunction: premature cognitive aging or neurodegenerative disease?. Alzheimer's Research & Therapy, Vol. 7, Issue. 1,

    Fialho, Renata Pereira, Marco Bucur, Mihaela Fisher, Martin Whale, Richard and Rusted, Jennifer 2015. Cognitive impairment in HIV and HCV co-infected patients: a systematic review and meta-analysis. AIDS Care, p. 1.

    Heikinheimo, T Poutiainen, E Salonen, O Elovaara, I and Ristola, M 2015. Three-decade neurological and neurocognitive follow-up of HIV-1-infected patients on best-available antiretroviral therapy in Finland. BMJ Open, Vol. 5, Issue. 11, p. e007986.

    Kore, Idil Ananworanich, Jintanat Valcour, Victor Fletcher, James L. K. Chalermchai, Thep Paul, Robert Reynolds, Jesse Tipsuk, Somporn Ubolyam, Sasiwimol Rattanamanee, Somprartthana Jagodzinski, Linda Kim, Jerome and Spudich, Serena 2015. Neuropsychological Impairment in Acute HIV and the Effect of Immediate Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes, Vol. 70, Issue. 4, p. 393.

    Matinella, Angela Lanzafame, M. Bonometti, M. A. Gajofatto, A. Concia, E. Vento, S. Monaco, S. and Ferrari, S. 2015. Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study. Journal of Neurology, Vol. 262, Issue. 5, p. 1317.

    Oliveira, Michelli Faria de Murrel, Ben Pérez-Santiago, Josué Vargas, Milenka Ellis, Ronald J. Letendre, Scott Grant, Igor Smith, Davey M. Woods, Steven Paul and Gianella, Sara 2015. Circulating HIV DNA Correlates With Neurocognitive Impairment in Older HIV-infected Adults on Suppressive ART. Scientific Reports, Vol. 5, p. 17094.

    Roy, Upal Atluri, Venkata S. R. Agudelo, Marisela Yndart, Adriana Huang, Zaohua and Nair, Madhavan 2015. DJ1 expression downregulates in neuroblastoma cells (SK-N-MC) chronically exposed to HIV-1 and cocaine. Frontiers in Microbiology, Vol. 6,

    Ruan, Qingwei Yu, Zhuowei Chen, Ma Bao, Zhijun Li, Jin and He, Wei 2015. Cognitive frailty, a novel target for the prevention of elderly dependency. Ageing Research Reviews, Vol. 20, p. 1.

    Su, Tanja Schouten, Judith Geurtsen, Gert J. Wit, Ferdinand W. Stolte, Ineke G. Prins, Maria Portegies, Peter Caan, Matthan W.A. Reiss, Peter Majoie, Charles B. and Schmand, Ben A. 2015. Multivariate normative comparison, a novel method for more reliably detecting cognitive impairment in HIV infection. AIDS, p. 1.

    Caldwell, J. Z. K. Gongvatana, A. Navia, B. A. Sweet, L. H. Tashima, K. Ding, M. and Cohen, R. A. 2014. Neural dysregulation during a working memory task in human immunodeficiency virus-seropositive and hepatitis C coinfected individuals. Journal of NeuroVirology, Vol. 20, Issue. 4, p. 398.

  • Journal of the International Neuropsychological Society, Volume 18, Issue 1
  • January 2012, pp. 68-78

Neurocognitive Effects of HIV, Hepatitis C, and Substance Use History

  • Kathryn N. Devlin (a1), Assawin Gongvatana (a1) (a2), Uraina S. Clark (a1) (a2), Jesse D. Chasman (a1) (a2), Michelle L. Westbrook (a1) (a3), Karen T. Tashima (a3) (a4), Bradford Navia (a5) and Ronald A. Cohen (a1) (a2)
  • DOI:
  • Published online: 02 December 2011

HIV-associated neurocognitive dysfunction persists in the highly active antiretroviral therapy (HAART) era and may be exacerbated by comorbidities, including substance use and hepatitis C virus (HCV) infection. However, the neurocognitive impact of HIV, HCV, and substance use in the HAART era is still not well understood. In the current study, 115 HIV-infected and 72 HIV-seronegative individuals with significant rates of lifetime substance dependence and HCV infection received comprehensive neuropsychological assessment. We examined the effects of HIV serostatus, HCV infection, and substance use history on neurocognitive functioning. We also examined relationships between HIV disease measures (current and nadir CD4, HIV RNA, duration of infection) and cognitive functioning. Approximately half of HIV-infected participants exhibited neurocognitive impairment. Detectable HIV RNA but not HIV serostatus was significantly associated with cognitive functioning. HCV was among the factors most consistently associated with poorer neurocognitive performance across domains, while substance use was less strongly associated with cognitive performance. The results suggest that neurocognitive impairment continues to occur in HIV-infected individuals in association with poor virologic control and comorbid conditions, particularly HCV coinfection. (JINS, 2012, 18, 68–78)

Corresponding author
Correspondence and reprint requests to: Ronald A. Cohen, Centers for Behavioral & Preventive Medicine, Coro Building, Suite 314, One Hoppin Street, Providence, RI 02903. E-mail:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

B.M. Ances , F. Vaida , M.J. Yeh , C.L. Liang , R.B. Buxton , S. Letendre , R.J. Ellis (2010). HIV infection and aging independently affect brain function as measured by functional magnetic resonance imaging. Journal of Infectious Diseases, 201(3), 336340.

G.L. Armstrong , A. Wasley , E.P. Simard , G.M. McQuillan , W.L. Kuhnert , M.J. Alter (2006). The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Annals of Internal Medicine, 144(10), 705714.

J.S. Bajaj , J.B. Wade , A.J. Sanyal (2009). Spectrum of neurocognitive impairment in cirrhosis: Implications for the assessment of hepatic encephalopathy. Hepatology, 50(6), 20142021.

M.R. Basso , R.A. Bornstein (2000). Neurobehavioural consequences of substance abuse and HIV infection. Journal of Psychopharmacology, 14(3), 228237.

R.H.B. Benedict , A. Schretlen , L. Groninger , J. Brandt (1998). Hopkins Verbal Learning Test Revised: Normative data and analysis of inter-form and test-retest reliability. The Clinical Neuropsychologist, 12, 4355.

R.H.B. Benedict , D. Schretlen , L. Groninger , M. Dobraski , B. Shpritz (1996). Revision of the Brief Visuospatial Memory Test: Studies of normal performance, reliability, and validity. Psychological Assessment, 8(2), 145153.

I. Bica , B. McGovern , R. Dhar , D. Stone , K. McGowan , R. Scheib , D.R. Snydman (2001). Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clinical Infectious Diseases, 32(3), 492497.

B.J. Brew (2004). Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS, 18(Suppl. 1), S75S78.

B.J. Brew , S.M. Crowe , A. Landay , L.A. Cysique , G. Guillemin (2009). Neurodegeneration and ageing in the HAART era. Journal of Neuroimmune Pharmacology, 4(2), 163174.

T.T. Brown , S.R. Cole , X. Li , L.A. Kingsley , F.J. Palella , S.A. Riddler , A.S. Dobs (2005). Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Archives of Internal Medicine, 165(10), 11791184.

C.L. Carey , S.P. Woods , R. Gonzalez , E. Conover , T.D. Marcotte , I. Grant , R.K. Heaton (2004). Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. Journal of Clinical and Experimental Neuropsychology, 26(3), 307319.

F. Carrat , F. Bani-Sadr , S. Pol , E. Rosenthal , F. Lunel-Fabiani , A. Benzekri , C. Perronne (2004). Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: A randomized controlled trial. JAMA, 292(23), 28392848.

L. Chang , T. Ernst , M.D. Witt , N. Ames , M. Gaiefsky , E. Miller (2002). Relationships among brain metabolites, cognitive function, and viral loads in antiretroviral-naive HIV patients. Neuroimage, 17(3), 16381648.

Y. Chen , H. An , H. Zhu , T. Stone , J.K. Smith , C. Hall , W. Lin (2009). White matter abnormalities revealed by diffusion tensor imaging in non-demented and demented HIV+ patients. Neuroimage, 47(4), 11541162.

M. Cherner , R.J. Ellis , D. Lazzaretto , C. Young , M.R. Mindt , J.H. Atkinson , R.K. Heaton (2004). Effects of HIV-1 infection and aging on neurobehavioral functioning: Preliminary findings. AIDS, 18(Suppl. 1), S27S34.

M. Cherner , S. Letendre , R.K. Heaton , J. Durelle , J. Marquie-Beck , B. Gragg , I. Grant (2005). Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. Neurology, 64(8), 13431347.

E.A. Childs , R.H. Lyles , O.A. Selnes , B. Chen , E.N. Miller , B.A. Cohen , J.C. McArthur (1999). Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology, 52(3), 607613.

R.T. Chung , J. Andersen , P. Volberding , G.K. Robbins , T. Liu , K.E. Sherman , C. van der Horst (2004). Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. New England Journal of Medicine, 351(5), 451459.

D.B. Clifford (2008). HIV-associated neurocognitive disease continues in the antiretroviral era. Topics in HIV Medicine, 16(2), 9498.

D.B. Clifford , S.R. Evans , Y. Yang , R.M. Gulick (2005). The neuropsychological and neurological impact of hepatitis C virus co-infection in HIV-infected subjects. AIDS, 19(Suppl. 3), S64S71.

D.B. Clifford , M. Smurzynski , L.S. Park , T.M. Yeh , Y. Zhao , L. Blair , S.R. Evans (2009). Effects of active HCV replication on neurologic status in HIV RNA virally suppressed patients. Neurology, 73(4), 309314.

R.A. Cohen , R. Boland , R. Paul , K.T. Tashima , E.E. Schoenbaum , D.D. Celentano , C.C. Carpenter (2001). Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women. AIDS, 15(3), 341345.

R.A. Cohen , S. de la Monte , A. Gongvatana , H. Ombao , B. Gonzalez , K.N. Devlin , K.T. Tashima (2011). Plasma cytokine concentrations associated with HIV/hepatitis C coinfection are related to attention, executive and psychomotor functioning. Journal of Neuroimmunology, 233(1–2), 204210.

R.A. Cohen , J. Harezlak , A. Gongvatana , S. Buchthal , G. Schifitto , U. Clark , B. Navia (2010). Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes. Journal of Neurovirology, 16(6), 435444.

R.A. Cohen , J. Harezlak , G. Schifitto , G. Hana , U. Clark , A. Gongvatana , B. Navia (2010). Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era. Journal of Neurovirology, 16(1), 2532.

W.M. Compton , Y.F. Thomas , F.S. Stinson , B.F. Grant (2007). Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: Results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry, 64(5), 566576.

N.F. Crum , R.H. Riffenburgh , S. Wegner , B.K. Agan , S.A. Tasker , K.M. Spooner , M.R. Wallace (2006). Comparisons of causes of death and mortality rates among HIV-infected persons: Analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. Journal of Acquired Immune Deficiency Syndromes, 41(2), 194200.

L.A. Cysique , P. Maruff , B.J. Brew (2006). Variable benefit in neuropsychological function in HIV-infected HAART-treated patients. Neurology, 66(9), 14471450.

L.A. Cysique , F. Vaida , S. Letendre , S. Gibson , M. Cherner , S.P. Woods , R.J. Ellis (2009). Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy. Neurology, 73(5), 342348.

P.E. Davis , H. Liddiard , T.M. McMillan (2002). Neuropsychological deficits and opiate abuse. Drug and Alcohol Dependence, 67(1), 105108.

S.M. de la Monte , L. Longato , M. Tong , S. DeNucci , J.R. Wands (2009). The liver-brain axis of alcohol-mediated neurodegeneration: Role of toxic lipids. International Journal of Environmental Research and Public Health, 6(7), 20552075.

S.M. de la Monte , M. Tong , V. Nguyen , M. Setshedi , L. Longato , J.R. Wands (2010). Ceramide-mediated insulin resistance and impairment of cognitive-motor functions. Journal of Alzheimer's Disease, 21(3), 967984.

S.G. Deeks , A.N. Phillips (2009). HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ (Clinical Research Ed.), 338, a3172.

V. Di Sclafani , M. Tolou-Shams , L.J. Price , G. Fein (2002). Neuropsychological performance of individuals dependent on crack-cocaine, or crack-cocaine and alcohol, at 6 weeks and 6 months of abstinence. Drug and Alcohol Dependence, 66(2), 161171.

D.A. Eldreth , J.A. Matochik , J.L. Cadet , K.I. Bolla (2004). Abnormal brain activity in prefrontal brain regions in abstinent marijuana users. Neuroimage, 23(3), 914920.

R. Ellis , D. Langford , E. Masliah (2007). HIV and antiretroviral therapy in the brain: Neuronal injury and repair. Nature Reviews. Neuroscience, 8(1), 3344.

K.D. Ersche , L. Clark , M. London , T.W. Robbins , B.J. Sahakian (2006). Profile of executive and memory function associated with amphetamine and opiate dependence. Neuropsychopharmacology, 31(5), 10361047.

W. Fals-Stewart , J. Schafer , S. Lucente , T. Rustine , L. Brown (1994). Neurobehavioral consequences of prolonged alcohol and substance abuse: A review of findings and treatment implications. Clinical Psychology Review, 14(8), 755778.

G. Fein , J. Torres , L.J. Price , V. Di Sclafani (2006). Cognitive performance in long-term abstinent alcoholic individuals. Alcoholism, Clinical and Experimental Research, 30(9), 15381544.

M.J. Fernandez-Serrano , M. Perez-Garcia , J. Schmidt Rio-Valle , A. Verdejo-Garcia (2010). Neuropsychological consequences of alcohol and drug abuse on different components of executive functions. Journal of Psychopharmacology, 24(9), 13171332.

M.J. Fernandez-Serrano , M. Perez-Garcia , A. Verdejo-Garcia (2011). What are the specific vs. generalized effects of drugs of abuse on neuropsychological performance? Neuroscience and Biobehavioral Reviews, 35(3), 377406.

D.M. Forton , J.M. Allsop , I.J. Cox , G. Hamilton , K. Wesnes , H.C. Thomas , S.D. Taylor-Robinson (2005). A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection. AIDS, 19(Suppl. 3), S53S63.

D.M. Forton , J.M. Allsop , J. Main , G.R. Foster , H.C. Thomas , S.D. Taylor-Robinson (2001). Evidence for a cerebral effect of the hepatitis C virus. Lancet, 358(9275), 3839.

D.M. Forton , H.C. Thomas , C.A. Murphy , J.M. Allsop , G.R. Foster , J. Main , S.D. Taylor-Robinson (2002). Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology, 35(2), 433439.

A. Gongvatana , B.C. Schweinsburg , M.J. Taylor , R.J. Theilmann , S.L. Letendre , O.M. Alhassoon , I. Grant (2009). White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals. Journal of Neurovirology, 15(2), 187195.

B.F. Grant (1996). Prevalence and correlates of drug use and DSM-IV drug dependence in the United States: Results of the National Longitudinal Alcohol Epidemiologic Survey. Journal of Substance Abuse, 8(2), 195210.

J.E. Green , R.V. Saveanu , R.A. Bornstein (2004). The effect of previous alcohol abuse on cognitive function in HIV infection. American Journal of Psychiatry, 161(2), 249254.

S.A. Gruber , M.M. Silveri , D.A. Yurgelun-Todd (2007). Neuropsychological consequences of opiate use. Neuropsychology Review, 17(3), 299315.

J. Harezlak , S. Buchthal , M. Taylor , G. Schifitto , J. Zhong , E. Daar , B. Navia (2011). Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment. AIDS, 25(5), 625633.

D.S. Hasin , F.S. Stinson , E. Ogburn , B.F. Grant (2007). Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry, 64(7), 830842.

R.K. Heaton , D.B. Clifford , D.R. Franklin Jr., S.P. Woods , C. Ake , F. Vaida , I. Grant (2010). HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology, 75(23), 20872096.

R.C. Hilsabeck , S.A. Castellon , C.H. Hinkin (2005). Neuropsychological aspects of coinfection with HIV and hepatitis C virus. Clinical Infectious Diseases, 41(Suppl. 1), S38S44.

R.C. Hilsabeck , W. Perry , T.I. Hassanein (2002). Neuropsychological impairment in patients with chronic hepatitis C. Hepatology, 35(2), 440446.

C.H. Hinkin , S.A. Castellon , A.J. Levine , T.R. Barclay , E.J. Singer (2008). Neurocognition in individuals co-infected with HIV and hepatitis C. Journal of Addictive Diseases, 27(2), 1117.

R.S. Janssen , A.J. Saykin , L. Cannon , J. Campbell , P.F. Pinsky , N.A. Hessol , J.E. Kaplan (1989). Neurological and neuropsychological manifestations of HIV-1 infection: Association with AIDS-related complex but not asymptomatic HIV-1 infection. Annals of Neurology, 26(5), 592600.

T.L. Jernigan , S. Archibald , J.R. Hesselink , J.H. Atkinson , R.A. Velin , J.A. McCutchan , I. Grant (1993). Magnetic resonance imaging morphometric analysis of cerebral volume loss in human immunodeficiency virus infection. The HNRC Group. Archives of Neurology, 50(3), 250255.

S.H. Kellogg , P.F. McHugh , K. Bell , J.H. Schluger , R.P. Schluger , K.S. LaForge , M.J. Kreek (2003). The Kreek-McHugh-Schluger-Kellogg scale: A new, rapid method for quantifying substance abuse and its possible applications. Drug and Alcohol Dependence, 69(2), 137150.

W.R. Kim (2002). The burden of hepatitis C in the United States. Hepatology, 36(5 Suppl. 1), S30S34.

L. Kramer , E. Bauer , G. Funk , H. Hofer , W. Jessner , P. Steindl-Munda , P. Ferenci (2002). Subclinical impairment of brain function in chronic hepatitis C infection. Journal of Hepatology, 37(3), 349354.

T. Laskus , M. Radkowski , A. Bednarska , J. Wilkinson , D. Adair , M. Nowicki , J. Rakela (2002). Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid. Journal of Virology, 76(19), 1006410068.

S.L. Letendre , J.A. McCutchan , M.E. Childers , S.P. Woods , D. Lazzaretto , R.K. Heaton , R.J. Ellis (2004). Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders. Annals of Neurology, 56(3), 416423.

S.L. Letendre , A.D. Paulino , E. Rockenstein , A. Adame , L. Crews , M. Cherner , E. Masliah (2007). Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV. Journal of Infectious Diseases, 196(3), 361370.

T. Lundqvist (2005). Cognitive consequences of cannabis use: Comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions. Pharmacology, Biochemistry and Behavior, 81(2), 319330.

E.M. Martin-Thormeyer , R.H. Paul (2009). Drug abuse and hepatitis C infection as comorbid features of HIV associated neurocognitive disorder: Neurocognitive and neuroimaging features. Neuropsychology Review, 19(2), 215231.

J.C. McArthur (2004). HIV dementia: An evolving disease. Journal of Neuroimmunology, 157(1–2), 310.

J.C. McArthur , D.R. McClernon , M.F. Cronin , T.E. Nance-Sproson , A.J. Saah , M. St Clair , E.R. Lanier (1997). Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Annals of Neurology, 42(5), 689698.

M. McCrea , J. Cordoba , G. Vessey , A.T. Blei , C. Randolph (1996). Neuropsychological characterization and detection of subclinical hepatic encephalopathy. Archives of Neurology, 53(8), 758763.

J.A. McCutchan , J.W. Wu , K. Robertson , S.L. Koletar , R.J. Ellis , S. Cohn , P.L. Williams (2007). HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients. AIDS, 21(9), 11091117.

A. Mocroft , B. Ledergerber , C. Katlama , O. Kirk , P. Reiss , A. d'Arminio Monforte , J.D. Lundgren (2003). Decline in the AIDS and death rates in the EuroSIDA study: An observational study. Lancet, 362(9377), 2229.

H.K. Monga , M.C. Rodriguez-Barradas , K. Breaux , K. Khattak , C.L. Troisi , M. Velez , B. Yoffe (2001). Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection. Clinical Infectious Diseases, 33(2), 240247.

D.J. Moore , E. Masliah , J.D. Rippeth , R. Gonzalez , C.L. Carey , M. Cherner , I. Grant (2006). Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment. AIDS, 20(6), 879887.

S. Morgello , L. Estanislao , E. Ryan , P. Gerits , D. Simpson , S. Verma , V. Sharp (2005). Effects of hepatic function and hepatitis C virus on the nervous system assessment of advanced-stage HIV-infected individuals. AIDS, 19(Suppl. 3), S116S122.

A. Nath , W.F. Maragos , M.J. Avison , F.A. Schmitt , J.R. Berger (2001). Acceleration of HIV dementia with methamphetamine and cocaine. Journal of Neurovirology, 7(1), 6671.

S. O'Malley , M. Adamse , R.K. Heaton , F.H. Gawin (1992). Neuropsychological impairment in chronic cocaine abusers. American Journal of Drug and Alcohol Abuse, 18(2), 131144.

N. Obel , H.F. Thomsen , G. Kronborg , C.S. Larsen , P.R. Hildebrandt , H.T. Sorensen , J. Gerstoft (2007). Ischemic heart disease in HIV-infected and HIV-uninfected individuals: A population-based cohort study. Clinical Infectious Diseases, 44(12), 16251631.

F.J. Palella Jr., R.K. Baker , A.C. Moorman , J.S. Chmiel , K.C. Wood , J.T. Brooks , S.D. Holmberg (2006). Mortality in the highly active antiretroviral therapy era: Changing causes of death and disease in the HIV outpatient study. Journal of Acquired Immune Deficiency Syndromes, 43(1), 2734.

R.H. Paul , C.T. Yiannoutsos , E.N. Miller , L. Chang , C.M. Marra , G. Schifitto , B.A. Navia (2007). Proton MRS and neuropsychological correlates in AIDS dementia complex: Evidence of subcortical specificity. Journal of Neuropsychiatry and Clinical Neurosciences, 19(3), 283292.

W. Perry , R.C. Hilsabeck , T.I. Hassanein (2008). Cognitive dysfunction in chronic hepatitis C: A review. Digestive Diseases and Sciences, 53(2), 307321.

L.M. Pezawas , G. Fischer , K. Diamant , C. Schneider , S.D. Schindler , M. Thurnher , S. Kasper (1998). Cerebral CT findings in male opioid-dependent patients: Stereological, planimetric and linear measurements. Psychiatry Research, 83(3), 139147.

A.N. Phillips , J. Neaton , J.D. Lundgren (2008). The role of HIV in serious diseases other than AIDS. AIDS, 22(18), 24092418.

N. Pomara , D.T. Crandall , S.J. Choi , G. Johnson , K.O. Lim (2001). White matter abnormalities in HIV-1 infection: A diffusion tensor imaging study. Psychiatry Research, 106(1), 1524.

T. Powles , D. Robinson , J. Stebbing , J. Shamash , M. Nelson , B. Gazzard , M. Bower (2009). Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. Journal of Clinical Oncology, 27(6), 884890.

L.S. Radloff (1977). The CES-D Scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1(3), 385401.

J.D. Rippeth , R.K. Heaton , C.L. Carey , T.D. Marcotte , D.J. Moore , R. Gonzalez , I. Grant (2004). Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. Journal of the International Neuropsychological Society, 10(1), 114.

K.R. Robertson , W.T. Robertson , S. Ford , D. Watson , S. Fiscus , A.G. Harp , C.D. Hall (2004). Highly active antiretroviral therapy improves neurocognitive functioning. Journal of Acquired Immune Deficiency Syndromes, 36(1), 562566.

K.R. Robertson , M. Smurzynski , T.D. Parsons , K. Wu , R.J. Bosch , J. Wu , R.J. Ellis (2007). The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS, 21(14), 19151921.

E.L. Ryan , S. Morgello , K. Isaacs , M. Naseer , P. Gerits (2004). Neuropsychiatric impact of hepatitis C on advanced HIV. Neurology, 62(6), 957962.

N. Sacktor , M.P. McDermott , K. Marder , G. Schifitto , O.A. Selnes , J.C. McArthur , L. Epstein (2002). HIV-associated cognitive impairment before and after the advent of combination therapy. Journal of Neurovirology, 8(2), 136142.

K.E. Sherman , S.D. Rouster , R.T. Chung , N. Rajicic (2002). Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: A cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clinical Infectious Diseases, 34(6), 831837.

R.A. Stern , J.E. Arruda , J.A. Somerville , R.A. Cohen , R.J. Boland , M.D. Stein , E.M. Martin (1998). Neurobehavioral functioning in asymptomatic HIV-1 infected women. Journal of the International Neuropsychological Society, 4(2), 172178.

D.M. Stoff (2004). Mental health research in HIV/AIDS and aging: Problems and prospects. AIDS, 18(Suppl. 1), S3S10.

P.M. Thompson , R.A. Dutton , K.M. Hayashi , A.W. Toga , O.L. Lopez , H.J. Aizenstein , J.T. Becker (2005). Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline. Proceedings of the National Academy of Sciences of the United States of America, 102(43), 1564715652.

V. Tozzi , P. Balestra , R. Bellagamba , A. Corpolongo , M.F. Salvatori , U. Visco-Comandini , P. Narciso (2007). Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: Prevalence and risk factors. Journal of Acquired Immune Deficiency Syndromes, 45(2), 174182.

V. Tozzi , P. Balestra , P. Lorenzini , R. Bellagamba , S. Galgani , A. Corpolongo , P. Narciso (2005). Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: Results from an urban observational cohort. Journal of Neurovirology, 11(3), 265273.

V.G. Valcour , C.M. Shikuma , M.R. Watters , N.C. Sacktor (2004). Cognitive impairment in older HIV-1-seropositive individuals: Prevalence and potential mechanisms. AIDS, 18(Suppl. 1), S79S86.

V.G. Valcour , P. Yee , A.E. Williams , B. Shiramizu , M. Watters , O. Selnes , N. Sacktor (2006). Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection--The Hawaii Aging with HIV Cohort. Journal of Neurovirology, 12(5), 387391.

W.G. van Gorp , J.N. Wilkins , C.H. Hinkin , L.H. Moore , J. Hull , M.D. Horner , D. Plotkin (1999). Declarative and procedural memory functioning in abstinent cocaine abusers. Archives of General Psychiatry, 56(1), 8589.

D. Wechsler (1997). Wechsler Adult Intelligence Scale-III (WAIS-III). San Antonio, TX: The Psychological Corporation.

K. Weissenborn , J. Krause , M. Bokemeyer , H. Hecker , A. Schuler , J.C. Ennen , K.W. Boker (2004). Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy. Journal of Hepatology, 41(5), 845851.

J. Wilkinson , M. Radkowski , T. Laskus (2009). Hepatitis C virus neuroinvasion: Identification of infected cells. Journal of Virology, 83(3), 13121319.

S.P. Woods , D.J. Moore , E. Weber , I. Grant (2009). Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychology Review, 19(2), 152168.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Journal of the International Neuropsychological Society
  • ISSN: 1355-6177
  • EISSN: 1469-7661
  • URL: /core/journals/journal-of-the-international-neuropsychological-society
Please enter your name
Please enter a valid email address
Who would you like to send this to? *